English | Español
Patient Daily | Feb 10, 2026

Sanofi reports mixed phase III results for rare disease drug venglustat
Patient Daily | Feb 10, 2026

Eli Lilly invests $3.5 billion in Pennsylvania obesity drug manufacturing plant
Patient Daily | Feb 10, 2026

GSK ends partnership on WVE-006 for AATD; future collaborations with Wave continue
Patient Daily | Feb 10, 2026

FDA prepares decisions on key therapies from REGENXBIO, Merck, Sanofi/Regeneron
Patient Daily | Feb 10, 2026

Penn Medicine expands holistic cancer care with Whole Person Care Collaborative
Patient Daily | Feb 10, 2026

Penn Medicine study finds rising use of methadone but calls for wider access
Patient Daily | Feb 10, 2026

Regulating immune response could help protect neurons in Parkinson’s disease
Patient Daily | Feb 10, 2026

Study finds people feel more empathy for loved ones’ internal bodily pain

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science